Page 35 - Read Online

Woods et al. J Cancer Metastasis Treat 2022;8:22 https://dx.doi.org/10.20517/2394-4722.2022.28 Page 11 of 14

managed with surgery alone. Ann Surg Oncol 2009;16:2985-93. DOI PubMed
32. Fagan J, Brooks J, Ramsey ML. Basal cell cancer. Treasure Island, FL: StatPearls, 2022.
33. Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011.
JAMA Dermatol 2013;149:615-6. DOI PubMed
34. Morgan FC, Ruiz ES, Karia PS, Besaw RJ, Neel VA, Schmults CD. Factors predictive of recurrence, metastasis, and death from
primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol 2020;83:832-8. DOI PubMed
35. McCusker M, Basset-Seguin N, Dummer R, et al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread
of disease. Eur J Cancer 2014;50:774-83. DOI PubMed
36. Nguyen-Nielsen M, Wang L, Pedersen L, et al. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010.
Eur J Dermatol 2015;25:463-8. DOI PubMed
37. Martinez SR, Barr KL, Canter RJ. Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors.
Arch Dermatol 2011;147:1058-62. DOI PubMed
38. Storino A, Drews RE, Tawa NE Jr. Malignant cutaneous adnexal tumors and role of SLNB. J Am Coll Surg 2021;232:889-98. DOI
PubMed
39. Barnes M, Hestley A, Murray DR, Carlson GW, Parker D, Delman KA. The risk of lymph node involvement in malignant cutaneous
adnexal tumors. Am Surg 2014;80:270-4. PubMed
40. Ogata D, Kiyohara Y, Yoshikawa S, Kasami M. Treatment strategy for cutaneous apocrine carcinoma. Int J Clin Oncol 2014;19:712-
5. DOI PubMed
41. Conic RRZ, Damiani G, Frigerio A, et al. Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study. J Am
Acad Dermatol 2020;83:809-16. DOI PubMed
42. Wollina U, Schönlebe J, Bujok V, et al. Dermal pleomorphic sarcoma of the scalp - report of two cases. Open Access Maced J Med
Sci 2019;7:2982-4. DOI PubMed PMC
43. Tillman BN, Liu JC. Cutaneous Sarcomas. Otolaryngol Clin North Am 2021;54:369-78. DOI PubMed
44. Sood A, Wykes J, Roshan D, et al. A critical analysis of the prognostic performance of the 8th edition American Joint Committee on
Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck. Head Neck 2019;41:1591-6. DOI PubMed
45. Moody SA, Hirsch BE, Myers EN. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J
Otol 2000;21:582-8. PubMed
46. Ruiz ES, Karia PS, Besaw R, Schmults CD. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs
the Brigham and Women’s Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma. JAMA Dermatol
2019;155:819-25. DOI PubMed PMC
47. Roscher I, Falk RS, Vos L, et al. Validating 4 staging systems for cutaneous squamous cell carcinoma using population-based data: a
nested case-control study. JAMA Dermatol 2018;154:428-34. DOI PubMed
48. Luk PP, Ebrahimi A, Veness MJ, et al. Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system
for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study. Head Neck 2021;43:558-67. DOI
PubMed
49. Ebrahimi A, Luk PP, Low H, et al. The American Joint Committee on Cancer staging for metastatic head and neck cutaneous
squamous cell carcinoma: A multi-institutional study of within-stage heterogeneity and impact on prognostic performance. Head
Neck 2020;42:3235-42. DOI PubMed
50. Amit M, Liu C, Gleber-Netto FO, et al. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell
carcinoma of the head and neck. Cancer 2021;127:1238-45. DOI PubMed
51. Sood A, Wykes J, Roshan D, et al. Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of
the head and neck. ANZ J Surg 2019;89:863-7. DOI PubMed
52. Lubov J, Labbé M, Sioufi K, et al. Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review. J
Otolaryngol Head Neck Surg 2021;50:54. DOI PubMed PMC
53. Clark JR, Rumcheva P, Veness MJ. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal
staging system for metastatic cutaneous squamous cell carcinoma of the head and neck. Ann Surg Oncol 2012;19:4252-8. DOI
PubMed
54. Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American Joint Committee
on Cancer, International Union Against Cancer, and Brigham and Women’s Hospital tumor staging for cutaneous squamous cell
carcinoma. J Clin Oncol 2014;32:327-34. DOI PubMed PMC
55. Forest VI, Clark JJ, Veness MJ, Milross C. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma
with lymph node metastases: results of 2 Australian Cancer Centers. Cancer 2010;116:1298-304. DOI PubMed
56. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and
pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002;24:417-22. DOI PubMed
57. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the
Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to
improve survival. Cancer 2009;115:1883-91. DOI PubMed
58. Moshiri AS, Nghiem P. Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw
2014;12:1255-62. DOI PubMed PMC